| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Source: https://www.va.gov/opal/nac/fss/pharmPrices.asp | ||||||||||||||||||
2 | Contract Number | Vendor Name | Contract Start Date | Contract Stop Date | NDC With Dashes | Sub-Item Identifier | Package Description | Generic | Trade Name | Trade name short | VA Class | Covered | Prime Vendor | Price | Price Start Date | Price Stop Date | Price Type | Non-TAA | |
3 | 36E79720D0016 | GlaxoSmithKline LLC | 03/15/2020 | 03/14/2021 | 58160-0885-52 | 10X0.5ML | INFLUENZA VACCINE,QUADRIVALENT (PF),SYRINGE,0.5ML | FLUARIX QUAD 2020-2021 (PF) | FLUARIX | IM900 | T | F | 124.08 | 03/15/2020 | 03/31/2021 | NC | Compliant | ||
4 | 36E79720D0021 | Sanofi Pasteur | 03/15/2020 | 03/14/2021 | 49281-0120-65 | 10X0.5ML | INFLUENZA VACCINE,QUADRIVALENT,HIGH-DOSE(PF),SYRINGE,0.5ML | FLUZONE QUADRIVALENT HIGH-DOSE 2020-2021 (PF) | FLUZONE | IM100 | T | F | 335.97 | 03/15/2020 | 03/31/2021 | NC | Compliant | ||
5 | 36E79720D0021 | Sanofi Pasteur | 03/15/2020 | 03/14/2021 | 49281-0633-15 | 5ML | INFLUENZA VACCINE,QUADRIVALENT (PF),VIL,0.5ML | FLUZONE QUAD 2020-2021 (MDV) | FLUZONE | IM900 | T | F | 128.68 | 03/15/2020 | 03/31/2021 | NC | Compliant | ||
6 | 36F79718D0436 | Dynavax Technologies Corporation | 05/01/2018 | 04/30/2023 | 43528-0003-05 | 5X0.5ML | HEPATITIS B VACCINE (RECOMBINANT) 20MCG/0.5ML INJ | HEPLISAV-B (RECOMBINANT) 20MCG/0.5ML | HEPLISAV-B | IM100 | T | T | 388.19 | 01/01/2020 | 04/30/2023 | Big4 | Compliant | ||
7 | 36F79718D0436 | Dynavax Technologies Corporation | 05/01/2018 | 04/30/2023 | 43528-0003-05 | 5X0.5ML | HEPATITIS B VACCINE (RECOMBINANT) 20MCG/0.5ML INJ | HEPLISAV-B (RECOMBINANT) 20MCG/0.5ML | HEPLISAV-B | IM100 | T | T | 442.95 | 01/01/2020 | 04/30/2023 | FSS | Compliant | ||
8 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4045-41 | 10X0.5ML | PAPILLOMAVIRUS HUMAN QUADRIVALENT VACCINE INJ | GARDASIL VACCINCE INJ 0.5ML SDV | GARDASIL | IM100 | T | T | 1201.66 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
9 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4045-41 | 10X0.5ML | PAPILLOMAVIRUS HUMAN QUADRIVALENT VACCINE INJ | GARDASIL VACCINCE INJ 0.5ML SDV | GARDASIL | IM100 | T | T | 1481.47 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
10 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4047-20 | 25X2ML | ROTAVIRUS PENTAVALENT VACCINE LIVE SOLN ORAL 2ML | ROTATEQ LIVE ORAL VACCINE 2ML TUBE | ROTATEQ | IM100 | T | T | 1374.01 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
11 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4047-20 | 25X2ML | ROTAVIRUS PENTAVALENT VACCINE LIVE SOLN ORAL 2ML | ROTATEQ LIVE ORAL VACCINE 2ML TUBE | ROTATEQ | IM100 | T | T | 2033.81 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
12 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4047-41 | 10X2ML | ROTAVIRUS PENTAVALENT VACCINE LIVE SUSP,ORAL,2ML | ROTATEQ LIVE ORAL VACCINE 2ML TUBE | ROTATEQ | IM100 | T | T | 555.28 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
13 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4047-41 | 10X2ML | ROTAVIRUS PENTAVALENT VACCINE LIVE SUSP,ORAL,2ML | ROTATEQ LIVE ORAL VACCINE 2ML TUBE | ROTATEQ | IM100 | T | T | 813.5 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
14 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4093-02 | 10 | HEPATITIS B VACCINE (RECOMBINANT) 5MCG/0.5ML INJ,SYRINGE,0.5ML | RECOMBIVAX 5MCG/0.5ML | RECOMBIVAX | IM100 | T | T | 139.02 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
15 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4093-02 | 10 | HEPATITIS B VACCINE (RECOMBINANT) 5MCG/0.5ML INJ,SYRINGE,0.5ML | RECOMBIVAX 5MCG/0.5ML | RECOMBIVAX | IM100 | T | T | 139.02 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
16 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4094-02 | 10 | HEPATITIS B VACCINE (RECOMBINANT) 10mcg/0.5ml INJ SYRINGE 0.5ml | RECOMBIVAX 10MCG/ML | RECOMBIVAX | IM100 | T | T | 304.08 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
17 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4094-02 | 10 | HEPATITIS B VACCINE (RECOMBINANT) 10mcg/0.5ml INJ SYRINGE 0.5ml | RECOMBIVAX 10MCG/ML | RECOMBIVAX | IM100 | T | T | 341.76 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
18 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4095-02 | 10 | HEPATITIS A VACCINE,INACTIVATED 25UNIT/0.5ML INJ,SYRINGE,0.5ML | VAQTA 25U/0.5ML | VAQTA | IM100 | T | T | 181.54 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
19 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4095-02 | 10 | HEPATITIS A VACCINE,INACTIVATED 25UNIT/0.5ML INJ,SYRINGE,0.5ML | VAQTA 25U/0.5ML | VAQTA | IM100 | T | T | 275.76 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
20 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4096-02 | 10 | HEPATITIS A VIRUS VACCINE/PF 50 UNIT/ML, SYR | VAQTA 50 UNITS/ML | VAQTA | IM100 | T | T | 359.57 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
21 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4096-02 | 10 | HEPATITIS A VIRUS VACCINE/PF 50 UNIT/ML, SYR | VAQTA 50 UNITS/ML | VAQTA | IM100 | T | T | 359.57 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
22 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4119-03 | 10X0.5ML | PAPILLOMAVIRUS HUMAN 9-VALENT VACCINE INJ | GARDASIL 9/0.5ML SDV | GARDASIL | IM100 | T | T | 1364.58 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
23 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4119-03 | 10X0.5ML | PAPILLOMAVIRUS HUMAN 9-VALENT VACCINE INJ | GARDASIL 9/0.5ML SDV | GARDASIL | IM100 | T | T | 2130.68 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
24 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4121-02 | 10X0.5ML | PAPILLOMAVIRUS HUMAN 9-VALENT VACCINE INJ | GARDASIL 9 /0.5ML PFS | GARDASIL | IM100 | T | T | 1412.9 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
25 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4121-02 | 10X0.5ML | PAPILLOMAVIRUS HUMAN 9-VALENT VACCINE INJ | GARDASIL 9 /0.5ML PFS | GARDASIL | IM100 | T | T | 2130.68 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
26 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4171-00 | 10 | MEASLES/MUMPS/RUBELLA/VARICELLA VIRUS VACCINE,LIVE INJ | PROQUAD 0.5ML/DOSE VACCINE 10SDV | PROQUAD | IM100 | T | T | 1371.74 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
27 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4171-00 | 10 | MEASLES/MUMPS/RUBELLA/VARICELLA VIRUS VACCINE,LIVE INJ | PROQUAD 0.5ML/DOSE VACCINE 10SDV | PROQUAD | IM100 | T | T | 2082.56 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
28 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4681-00 | 10 | MEASLES/MUMPS/RUBELLA VIRUS VACCINE,LIVE INJ | M-M-R II | M-M-R | IM100 | T | T | 490.95 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
29 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4681-00 | 10 | MEASLES/MUMPS/RUBELLA VIRUS VACCINE,LIVE INJ | M-M-R II | M-M-R | IM100 | T | T | 729.3 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
30 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4827-00 | 10X0.5ML | VARIVAX VACCINE INJ | VARIVAX | VARIVAX | IM100 | T | T | 824.47 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
31 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4827-00 | 10X0.5ML | VARIVAX VACCINE INJ | VARIVAX | VARIVAX | IM100 | T | T | 1282.06 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
32 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4831-41 | 10X0.5ML | HEPATITIS A VACCINE,INACTIVATED 25UNT/0.5ML INJ,VIL,0.5ML | VAQTA 25U/0.5ML INJ SDV | VAQTA | IM100 | T | T | 163.73 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
33 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4831-41 | 10X0.5ML | HEPATITIS A VACCINE,INACTIVATED 25UNT/0.5ML INJ,VIL,0.5ML | VAQTA 25U/0.5ML INJ SDV | VAQTA | IM100 | T | T | 275.76 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
34 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4837-03 | 10X0.5ML | PNEUMOCOCCAL 23-VALENT POLYSACCHARIDE VACCINE,SYRINGE,0.5ML | PNEUMOVAX 0.5ML | PNEUMOVAX | IM100 | T | T | 630.04 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
35 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4837-03 | 10X0.5ML | PNEUMOCOCCAL 23-VALENT POLYSACCHARIDE VACCINE,SYRINGE,0.5ML | PNEUMOVAX 0.5ML | PNEUMOVAX | IM100 | T | T | 993.34 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
36 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4841-00 | 1ML | HEPATITIS A VACCINE,INACTIVATED 50UNT/ML INJ,VIL,1ML | VAQTA 50U/1.0ML DOSE, SDV | VAQTA | IM100 | T | T | 20.75 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
37 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4841-00 | 1ML | HEPATITIS A VACCINE,INACTIVATED 50UNT/ML INJ,VIL,1ML | VAQTA 50U/1.0ML DOSE, SDV | VAQTA | IM100 | T | T | 35.91 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
38 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4841-41 | 10X1ML | HEPATITIS A VACCINE,INACTIVATED 50UNT/ML INJ,VIL,1ML | VAQTA 50U/ML INJ 1ML SDV | VAQTA | IM100 | T | T | 359.57 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
39 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4841-41 | 10X1ML | HEPATITIS A VACCINE,INACTIVATED 50UNT/ML INJ,VIL,1ML | VAQTA 50U/ML INJ 1ML SDV | VAQTA | IM100 | T | T | 359.57 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
40 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4943-00 | 10X0.5ML | PNEUMOCOCCAL 23-VALENT POLYSACCHARIDE VACCINE | PNEUMOVAX INJ | PNEUMOVAX | IM100 | T | T | 628.4 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
41 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4943-00 | 10X0.5ML | PNEUMOCOCCAL 23-VALENT POLYSACCHARIDE VACCINE | PNEUMOVAX INJ | PNEUMOVAX | IM100 | T | T | 993.34 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
42 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4963-00 | 0.65ML | ZOSTER VACCINE LIVE (OKA/MERCK) INJ | ZOSTAVAX VACCINE INJ 0.65ML SDV | ZOSTAVAX | IM100 | T | T | 164.12 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
43 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4963-00 | 0.65ML | ZOSTER VACCINE LIVE (OKA/MERCK) INJ | ZOSTAVAX VACCINE INJ 0.65ML SDV | ZOSTAVAX | IM100 | T | T | 219.36 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
44 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4963-41 | 10X0.65ML | ZOSTER VACCINE LIVE (OKA/MERCK) INJ | ZOSTAVAX VACCINE INJ 0.65ML SDV | ZOSTAVAX | IM100 | T | T | 1552.98 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
45 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4963-41 | 10X0.65ML | ZOSTER VACCINE LIVE (OKA/MERCK) INJ | ZOSTAVAX VACCINE INJ 0.65ML SDV | ZOSTAVAX | IM100 | T | T | 2090.75 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
46 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4981-00 | 10X0.5ML | HEPATITIS B VACCINE (RECOMBINANT) 5MCG/0.5ML INJ,VIL,0.5ML | RECOMBIVAX 5MCG/0.5ML INJ | RECOMBIVAX | IM100 | T | T | 90.64 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
47 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4981-00 | 10X0.5ML | HEPATITIS B VACCINE (RECOMBINANT) 5MCG/0.5ML INJ,VIL,0.5ML | RECOMBIVAX 5MCG/0.5ML INJ | RECOMBIVAX | IM100 | T | T | 139.02 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
48 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4992-00 | 1 | HEPATITIS B VACCINE (RECOMBINANT) 40MCG/ML INJ,SUSP | RECOMBIVAX HB 40MCG/1ML VIAL | RECOMBIVAX | IM100 | T | T | 77.06 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
49 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4992-00 | 1 | HEPATITIS B VACCINE (RECOMBINANT) 40MCG/ML INJ,SUSP | RECOMBIVAX HB 40MCG/1ML VIAL | RECOMBIVAX | IM100 | T | T | 96.23 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
50 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4995-00 | 1 | HEPATITIS B VACCINE (RECOMBINANT) 10MCG/ML INJ,SUSP | RECOMBIVAX HB 10MCG/1ML VIAL | RECOMBIVAX | IM100 | T | T | 34.77 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
51 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4995-00 | 1 | HEPATITIS B VACCINE (RECOMBINANT) 10MCG/ML INJ,SUSP | RECOMBIVAX HB 10MCG/1ML VIAL | RECOMBIVAX | IM100 | T | T | 34.77 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
52 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4995-41 | 10 | HEPATITIS B VACCINE (RECOMBINANT) 10MCG/ML INJ,SUSP | RECOMBIVAX HB 10MCG/1ML VIAL | RECOMBIVAX | IM100 | T | T | 255.51 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
53 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00006-4995-41 | 10 | HEPATITIS B VACCINE (RECOMBINANT) 10MCG/ML INJ,SUSP | RECOMBIVAX HB 10MCG/1ML VIAL | RECOMBIVAX | IM100 | T | T | 341.76 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
54 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00052-0602-02 | 2ML | BCG,TICE 50MG/AMP VACCINE | TICE BCG | TICE | AN900 | T | T | 100.62 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
55 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00052-0602-02 | 2ML | BCG,TICE 50MG/AMP VACCINE | TICE BCG | TICE | AN900 | T | T | 130.98 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
56 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00052-0603-02 | 2ML | BCG VACCINE INJ | BCG VACCINE USP | BCG | IM100 | T | T | 107.87 | 01/01/2020 | 08/31/2023 | Big4 | Compliant | ||
57 | 36F79718D0509 | Merck Sharp & Dohme Corporation | 09/01/2018 | 08/31/2023 | 00052-0603-02 | 2ML | BCG VACCINE INJ | BCG VACCINE USP | BCG | IM100 | T | T | 130.98 | 01/01/2020 | 08/31/2023 | FSS | Compliant | ||
58 | 36F79719D0274 | ASTRAZENECA PHARMACEUTICALS LP | 09/30/2019 | 09/29/2024 | 66019-0306-10 | 10 | INFLUENZA LIVE VACCINE,QUADRIVALENT,NASAL | FLUMIST QUAD 2019-2020 | FLUMIST | IM700 | T | T | 181.58 | 12/15/2019 | 09/29/2024 | Big4 | Compliant | ||
59 | 36F79719D0274 | ASTRAZENECA PHARMACEUTICALS LP | 09/30/2019 | 09/29/2024 | 66019-0306-10 | 10 | INFLUENZA LIVE VACCINE,QUADRIVALENT,NASAL | FLUMIST QUAD 2019-2020 | FLUMIST | IM700 | T | T | 181.58 | 12/15/2019 | 09/29/2024 | FSS | Compliant | ||
60 | V797D-40269 | Pfizer, Inc. | 11/01/2014 | 06/30/2020 | 00005-0100-05 | 5X0.5ML | NEISSERIA MENINGITIDIS VACCINE (TRUMENBA) INJ,0.5ML,SYR | TRUMENBA 0.5ML 1X5 PFS US | TRUMENBA | IM100 | T | T | 481.83 | 01/01/2020 | 06/30/2020 | Big4 | Compliant | ||
61 | V797D-40269 | Pfizer, Inc. | 11/01/2014 | 06/30/2020 | 00005-0100-05 | 5X0.5ML | NEISSERIA MENINGITIDIS VACCINE (TRUMENBA) INJ,0.5ML,SYR | TRUMENBA 0.5ML 1X5 PFS US | TRUMENBA | IM100 | T | T | 608.16 | 01/01/2020 | 06/30/2020 | FSS | Compliant | ||
62 | V797D-40269 | Pfizer, Inc. | 11/01/2014 | 06/30/2020 | 00005-0100-10 | 10X0.5ML | NEISSERIA MENINGITIDIS VACCINE (TRUMENBA) INJ,0.5ML,SYR | TRUMENBA 0.5ML 1X10 PFS US | TRUMENBA | IM100 | T | T | 936.07 | 01/01/2020 | 06/30/2020 | Big4 | Compliant | ||
63 | V797D-40269 | Pfizer, Inc. | 11/01/2014 | 06/30/2020 | 00005-0100-10 | 10X0.5ML | NEISSERIA MENINGITIDIS VACCINE (TRUMENBA) INJ,0.5ML,SYR | TRUMENBA 0.5ML 1X10 PFS US | TRUMENBA | IM100 | T | T | 1216.31 | 01/01/2020 | 06/30/2020 | FSS | Compliant | ||
64 | V797D-40269 | Pfizer, Inc. | 11/01/2014 | 06/30/2020 | 00005-1971-02 | 10X0.5ML | PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE | PREVNAR 13 VACCINE 0.5ML VIAL | PREVNAR | IM900 | T | T | 1322.64 | 01/01/2020 | 06/30/2020 | Big4 | Compliant | ||
65 | V797D-40269 | Pfizer, Inc. | 11/01/2014 | 06/30/2020 | 00005-1971-02 | 10X0.5ML | PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE | PREVNAR 13 VACCINE 0.5ML VIAL | PREVNAR | IM900 | T | T | 1803.65 | 01/01/2020 | 06/30/2020 | FSS | Compliant | ||
66 | V797D-40269 | Pfizer, Inc. | 11/01/2014 | 06/30/2020 | 00005-1971-05 | 1X0.5ML | PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE/0.5ML | PREVNAR 13 VACCINE 0.5ML VIAL | PREVNAR | IM100 | T | T | 136.25 | 01/01/2020 | 06/30/2020 | Big4 | Compliant | ||
67 | V797D-40269 | Pfizer, Inc. | 11/01/2014 | 06/30/2020 | 00005-1971-05 | 1X0.5ML | PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE/0.5ML | PREVNAR 13 VACCINE 0.5ML VIAL | PREVNAR | IM100 | T | T | 186 | 01/01/2020 | 06/30/2020 | FSS | Compliant | ||
68 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0250-51 | 1ML | RABIES VACCINE 2.5UNT/VIL INJ | IMOVAX RABIES VACCINE INJ W/LL SYRINGE | IMOVAX | IM100 | T | T | 162.58 | 01/01/2020 | 12/14/2020 | Big4 | Compliant | ||
69 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0250-51 | 1ML | RABIES VACCINE 2.5UNT/VIL INJ | IMOVAX RABIES VACCINE INJ W/LL SYRINGE | IMOVAX | IM100 | T | T | 162.58 | 01/01/2020 | 12/14/2020 | FSS | Compliant | ||
70 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0286-10 | 10X1 | DIPHTHERIA/TETANUS TOXOIDS/PERTUSSIS,ACELLULAR VACCINE INJ | DAPTACEL INJ,SUSP 10X1 DOSE VIAL | DAPTACEL | IM109 | T | T | 148.53 | 01/01/2020 | 12/14/2020 | Big4 | Compliant | ||
71 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0286-10 | 10X1 | DIPHTHERIA/TETANUS TOXOIDS/PERTUSSIS,ACELLULAR VACCINE INJ | DAPTACEL INJ,SUSP 10X1 DOSE VIAL | DAPTACEL | IM109 | T | T | 194.8 | 01/01/2020 | 12/14/2020 | FSS | Compliant | ||
72 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0400-10 | 10X0.5ML | DIPHTHERIA/TETANUS TOXOIDS/PERTUSSIS VACCINE INJ | ADACEL VACCINE INJ | ADACEL | IM109 | T | T | 262.09 | 01/01/2020 | 12/14/2020 | Big4 | Compliant | ||
73 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0400-10 | 10X0.5ML | DIPHTHERIA/TETANUS TOXOIDS/PERTUSSIS VACCINE INJ | ADACEL VACCINE INJ | ADACEL | IM109 | T | T | 322.01 | 01/01/2020 | 12/14/2020 | FSS | Compliant | ||
74 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0400-20 | 5X0.5 | DIPHTHERIA/TETANUS TOXOIDS/PERTUSSIS VACCINE INJ | ADACEL | ADACEL | IM109 | T | T | 125.02 | 01/01/2020 | 12/14/2020 | Big4 | Compliant | ||
75 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0400-20 | 5X0.5 | DIPHTHERIA/TETANUS TOXOIDS/PERTUSSIS VACCINE INJ | ADACEL | ADACEL | IM109 | T | T | 159.51 | 01/01/2020 | 12/14/2020 | FSS | Compliant | ||
76 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0405-65 | 10X0.5ML | INFLUENZA VACCINE,TRIVALENT,HIGH-DOSE(PF),SYRINGE,0.5ML | FLUZONE HIGH-DOSE 2019-20 (PF) | FLUZONE | IM100 | T | F | 349 | 11/08/2019 | 12/14/2020 | Big4 | Compliant | ||
77 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0405-65 | 10X0.5ML | INFLUENZA VACCINE,TRIVALENT,HIGH-DOSE(PF),SYRINGE,0.5ML | FLUZONE HIGH-DOSE 2019-20 (PF) | FLUZONE | IM100 | T | F | 370.57 | 08/05/2019 | 12/14/2020 | FSS | Compliant | ||
78 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0419-10 | 10X0.5ML | INFLUENZA VACCINE,QUADRIVALENT (PF),VIL,0.5ML | FLUZONE QUAD 2019-2020 (PF) | FLUZONE | IM100 | T | F | 130.4 | 11/08/2019 | 12/14/2020 | Big4 | Compliant | ||
79 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0419-10 | 10X0.5ML | INFLUENZA VACCINE,QUADRIVALENT (PF),VIL,0.5ML | FLUZONE QUAD 2019-2020 (PF) | FLUZONE | IM100 | T | F | 138.98 | 08/05/2019 | 12/14/2020 | FSS | Compliant | ||
80 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0419-50 | 10X0.5ML | INFLUENZA VACCINE,QUADRIVALENT (PF),SYRINGE,0.5ML | FLUZONE QUAD 2019-2020 (PF) | FLUZONE | IM100 | T | F | 127.98 | 11/08/2019 | 12/14/2020 | Big4 | Compliant | ||
81 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0419-50 | 10X0.5ML | INFLUENZA VACCINE,QUADRIVALENT (PF),SYRINGE,0.5ML | FLUZONE QUAD 2019-2020 (PF) | FLUZONE | IM100 | T | F | 138.98 | 08/05/2019 | 12/14/2020 | FSS | Compliant | ||
82 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0510-05 | 5X0.5 | DIPHTHERIA/PERTUSSIS/POLIOVIRUS/TETANUS VACCINE INJ,0.5ML,SYR | PENTACEL VACCINE | PENTACEL | IM900 | T | T | 229.98 | 01/01/2020 | 12/14/2020 | Big4 | Compliant | ||
83 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0510-05 | 5X0.5 | DIPHTHERIA/PERTUSSIS/POLIOVIRUS/TETANUS VACCINE INJ,0.5ML,SYR | PENTACEL VACCINE | PENTACEL | IM900 | T | T | 302.35 | 01/01/2020 | 12/14/2020 | FSS | Compliant | ||
84 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0519-25 | 10X0.25ML | INFLUENZA VACCINE,QUADRIVALENT (PEDIATRIC)(PF),SYRINGE,0.25ML | FLUZONE QUAD PEDI 2019-20 (PF) | FLUZONE | IM100 | T | F | 123.19 | 11/08/2019 | 12/14/2020 | Big4 | Compliant | ||
85 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0519-25 | 10X0.25ML | INFLUENZA VACCINE,QUADRIVALENT (PEDIATRIC)(PF),SYRINGE,0.25ML | FLUZONE QUAD PEDI 2019-20 (PF) | FLUZONE | IM100 | T | F | 148.82 | 08/05/2019 | 12/14/2020 | FSS | Compliant | ||
86 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0545-03 | 5X0.5ML | HAEMOPHILUS B CONJUGATE VACCINE INJ | ACTHIB (PF) INJ SDV | ACTHIB | IM700 | T | T | 36.81 | 01/01/2020 | 12/14/2020 | Big4 | Compliant | ||
87 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0545-03 | 5X0.5ML | HAEMOPHILUS B CONJUGATE VACCINE INJ | ACTHIB (PF) INJ SDV | ACTHIB | IM700 | T | T | 47.15 | 01/01/2020 | 12/14/2020 | FSS | Compliant | ||
88 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0562-10 | 10X0.5ML | DIPHTHERIA/PERTUSSIS/POLIOVIRUS/TETANUS VACCINE INJ | QUADRACEL/0.5ML | QUADRACEL/0.5ML | IM900 | T | T | 291.39 | 01/01/2020 | 12/14/2020 | Big4 | Compliant | ||
89 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0562-10 | 10X0.5ML | DIPHTHERIA/PERTUSSIS/POLIOVIRUS/TETANUS VACCINE INJ | QUADRACEL/0.5ML | QUADRACEL/0.5ML | IM900 | T | T | 412.09 | 01/01/2020 | 12/14/2020 | FSS | Compliant | ||
90 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0589-05 | 5X0.5ML | DIPHTHERIA TOXOID/MENINGOCOCCAL POLYSACCHARIDE CONJ VACCINE | MENACTRA VACCINE INJ | MENACTRA | IM109 | T | T | 378.29 | 01/01/2020 | 12/14/2020 | Big4 | Compliant | ||
91 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0589-05 | 5X0.5ML | DIPHTHERIA TOXOID/MENINGOCOCCAL POLYSACCHARIDE CONJ VACCINE | MENACTRA VACCINE INJ | MENACTRA | IM109 | T | T | 501.87 | 01/01/2020 | 12/14/2020 | FSS | Compliant | ||
92 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0631-15 | 5ML | INFLUENZA VACCINE,QUADRIVALENT,VIL,5ML | FLUZONE QUAD 2019-2020 | FLUZONE | IM100 | T | F | 122.59 | 11/08/2019 | 12/14/2020 | Big4 | Compliant | ||
93 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0631-15 | 5ML | INFLUENZA VACCINE,QUADRIVALENT,VIL,5ML | FLUZONE QUAD 2019-2020 | FLUZONE | IM100 | T | F | 128.69 | 08/05/2019 | 12/14/2020 | FSS | Compliant | ||
94 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0719-10 | 10X0.5ML | INFLUENZA VACCINE,QUADRIVALENT (PF),SYRINGE,0.5ML | FLUBLOK QUAD 2019-2020 (PF) | FLUBLOK | IM100 | T | F | 306.61 | 11/08/2019 | 12/14/2020 | Big4 | Compliant | ||
95 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0719-10 | 10X0.5ML | INFLUENZA VACCINE,QUADRIVALENT (PF),SYRINGE,0.5ML | FLUBLOK QUAD 2019-2020 (PF) | FLUBLOK | IM100 | T | F | 370.57 | 08/05/2019 | 12/14/2020 | FSS | Compliant | ||
96 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0790-20 | 1X10ML | TYPHOID VI POLYSACCHARIDE (TYPHIM VI) VACCINE | TYPHIM VI VACCINE 20-DOSE VIAL | TYPHIM | IM100 | T | T | 837.11 | 01/01/2020 | 12/14/2020 | Big4 | Compliant | ||
97 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0790-20 | 1X10ML | TYPHOID VI POLYSACCHARIDE (TYPHIM VI) VACCINE | TYPHIM VI VACCINE 20-DOSE VIAL | TYPHIM | IM100 | T | T | 837.11 | 01/01/2020 | 12/14/2020 | FSS | Compliant | ||
98 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0790-51 | 1 | TYPHOID VI POLYSACCHARIDE (TYPHIM VI) VACCINE,SYRINGE,0.5ML | TYPHIM VI VACCINE 0.5ML SYRINGE LL | TYPHIM | IM100 | T | T | 53.83 | 01/01/2020 | 12/14/2020 | Big4 | Compliant | ||
99 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0790-51 | 1 | TYPHOID VI POLYSACCHARIDE (TYPHIM VI) VACCINE,SYRINGE,0.5ML | TYPHIM VI VACCINE 0.5ML SYRINGE LL | TYPHIM | IM100 | T | T | 53.83 | 01/01/2020 | 12/14/2020 | FSS | Compliant | ||
100 | V797D-50457 | Sanofi Pasteur | 12/15/2015 | 12/14/2020 | 49281-0860-10 | 1 | POLIOVIRUS VACCINE INACTIVATED INJ | IPOL 10-DOSE VIAL | IPOL | IM100 | T | T | 190.66 | 01/01/2020 | 12/14/2020 | Big4 | Compliant | ||